ArticleJournal of cellular and molecular medicine2018

Increased Dkk-1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms.

Cristina Mambet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.